Pharma IQ: In predictive toxicology what difference does the small molecule versus
large molecule make?
Stephen Kirk: The biggest difference is with regards to the small molecule there’s more of a structured process for predictive pre-clinical toxicological studies and you’re looking more for kind of off target toxicity, whereas with a larger molecule it’s very specific, so you’re looking more for an exaggerated pharmacology type response and looking for
specific t...
To continue reading this story Click Here
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More